ACL australian clinical labs limited

News: ACL Australian Clinical Labs Provides Update on ACCC Review Timeline On Takeover Offer for...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 22 (Reuters) - Australian Clinical Labs Ltd (ACL) :

    • ACL:TAKEOVER OFFER FOR HEALIUS-UPDATE - ACCC REVIEW TIMELINE,ACL
    • REFERS TO ITS OFF-MARKET TAKEOVER OFFER FOR ALL OF FULLY PAID ORDINARY SHARES ON ISSUE IN HEALIUS LIMITED
    • NOTES THAT ACCC HAS ADVISED ACL THAT IT HAS SUSPENDED TIMELINE ON ITS PUBLIC REGISTER OF ITS REVIEW OF PROPOSED MERGER
    • ACCC HAS NOT YET PUBLICLY STATED OR ADVISED ACL OF ITS NEW EXPECTED DECISION DATE
    • EFFECT OF SUSPENSION OF TIMELINE THAT DATE ACCC EXPECTS TO ANNOUNCE FINAL DECISION ON PROPOSED MERGER WILL BE DELAYED
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.60
Change
-0.030(1.14%)
Mkt cap ! $510.6M
Open High Low Value Volume
$2.64 $2.65 $2.59 $901.1K 345.8K

Buyers (Bids)

No. Vol. Price($)
3 18300 $2.60
 

Sellers (Offers)

Price($) Vol. No.
$2.62 2000 1
View Market Depth
Last trade - 16.10pm 05/09/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.